Omega Diagnostics Group PLC Exercise of Options and Total Voting Rights (7102T)
March 26 2021 - 12:36PM
UK Regulatory
TIDMODX
RNS Number : 7102T
Omega Diagnostics Group PLC
26 March 2021
26 March 2021
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company" or the "Group")
Exercise of Options and Total Voting Rights
Omega Diagnostics (AIM: ODX), the medical diagnostics company
focused on CD4, infectious diseases and food intolerance testing,
announces that it has agreed to allot in total 14,673 new ordinary
shares of 4 pence each in the capital of the Company ("Ordinary
Shares"). This is following the exercise of share options under the
Company's Sharesave scheme by Derek Brady, a PDMR of the Company,
at a price of 18.4p per Ordinary Share. Following this exercise,
Derek Brady holds 14,673 Ordinary Shares in the Company.
Application has been made to the London Stock Exchange for the
14,673 new Ordinary Shares to be admitted to trading on AIM
("Admission") and it is expected that Admission will become
effective and trading will commence at 8.00 a.m. on 1 April
2021.
After Admission, the total number of Ordinary Shares in issue
will be 182,269,796 and the total number of voting rights will
therefore be 182,269,796. This figure may be used by shareholders
as the denominator for the calculations by which they will
determine if they are required to notify their interest in, or a
change to their interest in, the share capital of the Company under
the FCA's Disclosure and Transparency Rules.
The information contained within this announcement is deemed by
the Company to constitute inside information stipulated under the
Market Abuse Regulation (EU) No. 596/2014.The below notification is
made in accordance with the requirements of the EU Market Abuse
Regulation.
Contacts:
Omega Diagnostics Group PLC Tel: 01259 763 030
Colin King, Chief Executive www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
finnCap Ltd Tel: 020 7220 0500
Geoff Nash / Teddy Whiley (Corporate
Finance)
Alice Lane (ECM)
Walbrook PR Limited Tel: 020 7933 8780 or
omega@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303
Notification of a Transaction pursuant to Article 19(1) of Regulation
(EU) No. 596/2014
1 Details of the person discharging managerial responsibilities/person
closely associated
---- ---------------------------------------------------------------------------------------
a. Name Derek Brady
----------------------------------------------------------
2 Reason for notification
--------------------------- ----------------------------------------------------------
a. Position/Status PDMR (Group Strategic Sourcing Director)
--------------------------- ----------------------------------------------------------
b. Initial notification/ Initial Notification
Amendment
--------------------------- ----------------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
---------------------------------------------------------------------------------------
a. Name Omega Diagnostics Group Plc
---------------------------
b. LEI 2138007U9P4BTZTYIR92
--------------------------- ----------------------------------------------------------
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
---- ---------------------------------------------------------------------------------------
a. Description of Ordinary Shares of 4 pence each
the financial
instrument, type ISIN: GB00B1VCP282
of instrument
Identification
Code
--------------------------- ----------------------------------------------------------
b. Nature of the Acquisition of Ordinary Shares following the
transaction Exercise of Share Options
--------------------------- ----------------------------------------------------------
c. Price(s) and volume(s) Price(s) Volume(s)
--------------------------- -------------
18.4p 14,673 Purchase
------------- -----------
d. Aggregated information As above.
--------------------------- ----------------------------------------------------------
e. Date of the transaction 26 March 2021
--------------------------- ----------------------------------------------------------
f. Place of the transaction London Stock Exchange
--------------------------- ----------------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRSEIFWMEFSEDD
(END) Dow Jones Newswires
March 26, 2021 13:36 ET (17:36 GMT)
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2023 to Apr 2024
